Page 4 - Anna Edney News Today

Sensing that Republicans are walking into a political minefield by threatening once again to repeal the Affordable Care Act, the Biden administration is looking to capitalize by rolling out a series of initiatives aimed at high drug prices and other consequences of “corporate greed in health care.” Meanwhile, the Supreme Court hears a case that could determine when and how much victims of the opioid crisis can collect from Purdue Pharma, the drug company that lied about how addictive its dru...

And the Judiciary, Ways and Means, and Oversight committees will jointly release an interim staff report on one of the Hunter Biden investigations.

And Donald Trump doesn’t intend to lift a finger to help Steve Scalise rally support.

Tens of thousands of lawsuits have their origins in a man once arrested after firing a gun into the ceiling of his Yale University frat house and threatening a visitor, resulting in police discovering an illegal arsenal of weapons and explosives that earned him a one-year prison sentence.

The Biden administration continued a bipartisan, decades-long effort to ensure that health insurance treats mental illnesses the same as other ailments, with a new set of regulations aimed at ensuring that services are actually available without years-long waits or excessive out-of-pocket costs.

President Joe Biden is kicking off his reelection campaign in part by trying to finish a decades-long effort to establish parity in insurance benefits between mental and physical health. Meanwhile, House Republicans are working to add abortion and other contentious amendments to must-pass spending bills. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Anna Edney of Bloomberg, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News’ chief Washington corre...

Two of the most widely used cancer drugs are in short supply amid one of the worst chemotherapy shortages in decades, forcing clinics across the US to ration the lifesaving medicines. Centers are altering treatment regimens, restricting the therapies to the cases most likely to be cured or sending patients…

The Department of Defense is talking with Valisure, a lab that specializes in checking the quality of pharmaceuticals, Bloomberg reported.

And the House is stuck in limbo.

As US drug shortages hit a five-year high and concerns mount about the safety of medicines, the Biden administration has quietly assembled a team to address chronic problems hurting America’s drug supply.